BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20374200)

  • 21. Interleukin-21 administration to aged mice rejuvenates their peripheral T-cell pool by triggering de novo thymopoiesis.
    Al-Chami E; Tormo A; Pasquin S; Kanjarawi R; Ziouani S; Rafei M
    Aging Cell; 2016 Apr; 15(2):349-60. PubMed ID: 26762709
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss.
    Fukunaga T; Zou W; Rohatgi N; Colca JR; Teitelbaum SL
    J Bone Miner Res; 2015 Mar; 30(3):481-8. PubMed ID: 25257948
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chemerin, a novel peroxisome proliferator-activated receptor gamma (PPARgamma) target gene that promotes mesenchymal stem cell adipogenesis.
    Muruganandan S; Parlee SD; Rourke JL; Ernst MC; Goralski KB; Sinal CJ
    J Biol Chem; 2011 Jul; 286(27):23982-95. PubMed ID: 21572083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of glucocorticoid-impaired thymus function by dihydromyricetin via up-regulation of PPARγ-associated fatty acid metabolism.
    Li T; Yan F; Meng X; Wang J; Ting Kam RK; Zeng X; Liu Z; Zhou H; Yang F; Ren R; Liao K; Liu L
    Pharmacol Res; 2018 Nov; 137():76-88. PubMed ID: 30227260
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tributyltin induces a transcriptional response without a brite adipocyte signature in adipocyte models.
    Kim S; Li A; Monti S; Schlezinger JJ
    Arch Toxicol; 2018 Sep; 92(9):2859-2874. PubMed ID: 30027469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ): AN INTEGRATED TWO-RECEPTOR SIGNALING PATHWAY.
    Wang S; Awad KS; Elinoff JM; Dougherty EJ; Ferreyra GA; Wang JY; Cai R; Sun J; Ptasinska A; Danner RL
    J Biol Chem; 2015 Aug; 290(32):19544-57. PubMed ID: 26105050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPARgamma by Cdk5.
    Choi JH; Banks AS; Estall JL; Kajimura S; Boström P; Laznik D; Ruas JL; Chalmers MJ; Kamenecka TM; Blüher M; Griffin PR; Spiegelman BM
    Nature; 2010 Jul; 466(7305):451-6. PubMed ID: 20651683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
    Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY
    Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bisphenol S- and bisphenol A-induced adipogenesis of murine preadipocytes occurs through direct peroxisome proliferator-activated receptor gamma activation.
    Ahmed S; Atlas E
    Int J Obes (Lond); 2016 Oct; 40(10):1566-1573. PubMed ID: 27273607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PPARγ agonist through the terminal differentiation phase is essential for adipogenic differentiation of fetal ovine preadipocytes.
    Pu Y; Veiga-Lopez A
    Cell Mol Biol Lett; 2017; 22():6. PubMed ID: 28536637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. GQ-16, a novel peroxisome proliferator-activated receptor γ (PPARγ) ligand, promotes insulin sensitization without weight gain.
    Amato AA; Rajagopalan S; Lin JZ; Carvalho BM; Figueira AC; Lu J; Ayers SD; Mottin M; Silveira RL; Souza PC; Mourão RH; Saad MJ; Togashi M; Simeoni LA; Abdalla DS; Skaf MS; Polikparpov I; Lima MC; Galdino SL; Brennan RG; Baxter JD; Pitta IR; Webb P; Phillips KJ; Neves FA
    J Biol Chem; 2012 Aug; 287(33):28169-79. PubMed ID: 22584573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormone-sensitive lipase modulates adipose metabolism through PPARγ.
    Shen WJ; Yu Z; Patel S; Jue D; Liu LF; Kraemer FB
    Biochim Biophys Acta; 2011 Jan; 1811(1):9-16. PubMed ID: 20950707
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Flightless-1, a novel transcriptional modulator of PPARγ through competing with RXRα.
    Choi JS; Choi SS; Kim ES; Seo YK; Seo JK; Kim EK; Suh PG; Choi JH
    Cell Signal; 2015 Mar; 27(3):614-20. PubMed ID: 25479590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Myeloid Elf-1-like factor stimulates adipogenic differentiation through the induction of peroxisome proliferator-activated receptor γ expression in bone marrow.
    Baek K; Cho JY; Hwang HR; Kwon A; Lee HL; Park HJ; Qadir AS; Ryoo HM; Woo KM; Baek JH
    J Cell Physiol; 2012 Nov; 227(11):3603-12. PubMed ID: 22307523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo.
    Lecka-Czernik B; Ackert-Bicknell C; Adamo ML; Marmolejos V; Churchill GA; Shockley KR; Reid IR; Grey A; Rosen CJ
    Endocrinology; 2007 Feb; 148(2):903-11. PubMed ID: 17122083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The farnesoid X receptor regulates adipocyte differentiation and function by promoting peroxisome proliferator-activated receptor-gamma and interfering with the Wnt/beta-catenin pathways.
    Abdelkarim M; Caron S; Duhem C; Prawitt J; Dumont J; Lucas A; Bouchaert E; Briand O; Brozek J; Kuipers F; Fievet C; Cariou B; Staels B
    J Biol Chem; 2010 Nov; 285(47):36759-67. PubMed ID: 20851881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ghrelin promotes thymopoiesis during aging.
    Dixit VD; Yang H; Sun Y; Weeraratna AT; Youm YH; Smith RG; Taub DD
    J Clin Invest; 2007 Oct; 117(10):2778-90. PubMed ID: 17823656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FK614, a novel peroxisome proliferator-activated receptor gamma modulator, induces differential transactivation through a unique ligand-specific interaction with transcriptional coactivators.
    Fujimura T; Sakuma H; Konishi S; Oe T; Hosogai N; Kimura C; Aramori I; Mutoh S
    J Pharmacol Sci; 2005 Dec; 99(4):342-52. PubMed ID: 16314690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retinaldehyde dehydrogenase 1 deficiency inhibits PPARγ-mediated bone loss and marrow adiposity.
    Nallamshetty S; Le PT; Wang H; Issacsohn MJ; Reeder DJ; Rhee EJ; Kiefer FW; Brown JD; Rosen CJ; Plutzky J
    Bone; 2014 Oct; 67():281-91. PubMed ID: 25064526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 17β-Estradiol inhibition of PPARγ-induced adipogenesis and adipocyte-specific gene expression.
    Jeong S; Yoon M
    Acta Pharmacol Sin; 2011 Feb; 32(2):230-8. PubMed ID: 21293475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.